title: Letter to the editor: acute effects of intravenous administration of pamidronate in patients with osteoporosis.
authors.forename: Annalisa
authors.initials: A
authors.lastname: Marcuzzi
authors.forename: Valentina
authors.initials: V
authors.lastname: Zanin
authors.forename: Josef
authors.initials: J
authors.lastname: Vuch
authors.forename: Alessandra
authors.initials: A
authors.lastname: Pontillo
authors.forename: Sergio
authors.initials: S
authors.lastname: Crovella
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D016207:Cytokines / Q000097:blood; D004164:Diphosphonates / Q000008:administration & dosage*; D006801:Humans; D007275:Injections, Intravenous; D010024:Osteoporosis / Q000188:drug therapy*; D000077268:Pamidronate
chemical_list: D000893:Anti-Inflammatory Agents; D016207:Cytokines; D004164:Diphosphonates; D000077268:Pamidronate